Ocuphire Pharma : 10-Q Filing Q1 2023
Item 2. Management's Discussion and Analysis of Financial Condition and Results of... | May 15, 2023
Source: marketscreener.com
Rexahn Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rexahn Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rexahn Pharmaceuticals Today - Breaking & Trending Today
MaxCyte installs Douglas Swirsky as its new finance chief
Cell engineering technology company MaxCyte announced the appointment of Douglas Swirsky as its new chief financial officer on Tuesday.
Source: sharecast.com
MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
ROCKVILLE, Md., March 27, 2023 -- MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization... | March 27, 2023
Source: marketscreener.com
Pancreatic Cancer Market to Progress at a CAGR of 7.3 % by 2032
/PRNewswire/ -- DelveInsight's Pancreatic Cancer Market Insights report includes a comprehensive understanding of current treatment practices, pancreatic...
Source: prnewswire.com
Global Antisense & RNAi Therapeutics Market Report 2022: A $2.14 Billion Market in 2026 from $1.42 Billion in 2022
/PRNewswire/ -- The "Antisense & RNAi Therapeutics Global Market Report 2022: By Technology, By Route, By Indication" report has been added to...
Source: prnewswire.com